Study population
prostate cancer
PROSTATE CANCER, LITTLE
The study populations for the budget impact analysis were drawn from men aged 50–69 years registered at participating GP practices within the 8 trial centres in England and Wales (Sheffield, Newcastle, Bristol, Cardiff, Birmingham, Leicester, Cambridge and Leeds). Men were excluded from CAP if they had a prostate cancer diagnosis prior to randomisation or they opted out. Little evidence was found of baseline differences between the GP practices who consented to participate in the intervention compared with control practices [